Zoetis Inc. Class A Common Stoc (ZTS) 45.46 $ZTS
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Your Weekly Review: Growth Stocks Show Signs Of Life
at Investor's Business Daily - Thu Feb 12, 5:12PM CST
The good news for growth investors is that the market is back in a confirmed uptrend. Even better news is that this week's Your Weekly Review screen shows plenty of compelling candidates. Despite nagging distribution days in the S&P 500 and Nasdaq,...
CBPO: 69.12 (+0.42), ZTS: 45.46 (-0.33), SSNC: 63.38 (+1.40), AAP: 150.16 (-1.26), ORLY: 205.55 (-1.02), MIDD: 105.62 (+1.51), SPR: 49.35 (+0.47), MPWR: 50.32 (+0.16), DATA: 99.90 (+1.40)
Must-See Charts: 5 Big Stocks With Breakout Potential
at The Street - Thu Feb 12, 10:14AM CST
Here's a technical look at how to trade some of the biggest stocks on Wall Street.
ZTS: 45.46 (-0.33), BF.A: 90.65 (-0.43), IBM: 160.40 (+1.88), ABX: 12.14 (+0.01), IP: 57.31 (+0.12)
Company News for February 12, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 9:10AM CST
Companies in the News are: MOS,ZTS,TWX,VOYA
ZTS: 45.46 (-0.33), VOYA: 43.19 (+0.14), MOS: 52.33 (+0.29), TWX: 83.87 (+0.56)
Zoetis achieves higher Q4 2014 net income of USD126m
M2 - Thu Feb 12, 7:13AM CST
Animal medicine company Zoetis (NYSE:ZTS) stated on Wednesday that it recorded net income of USD126m, or USD0.25 per diluted share, for the fourth quarter 2014.
ZTS: 45.46 (-0.33)
Greece Issue Is Blown Out Of Proportion - Cramer's Mad Money (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 6:44AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, February 11. It is the overseas issue again. Cramer thinks the critics have come back to cause investor fear on the Germany-Greece showdown. Cramer called it...
PBR.A: 7.13 (+0.48), SDRL: 12.32 (-0.70), GOOG: 549.01 (+6.08), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), ZTS: 45.46 (-0.33), JNJ: 99.62 (+1.18), CMG: 674.89 (+4.60), DNB: 133.27 (+0.46), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), DOW: 49.44 (+0.29), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Zoetis
at Investor's Business Daily - Wed Feb 11, 6:01PM CST
Zoetis (ZTS) EPS rose 11.1% to 40 cents, topping by 4 cents. Revenue increased 3.8% to $1.3 bil, above views for $1.27 bil. The animal health company sees full-year EPS of $1.61-$1.68 on revenue of $4.8 bil-$4.9 bil. Shares rose 4.2% to 45.77.
ZTS: 45.46 (-0.33)
Zoetis (ZTS) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Wed Feb 11, 12:42PM CST
The following Zoetis (ZTS) conference call took place on February 11, 2015, 08:30 AM ET. This is a transcript of that earnings call:
ZTS: 45.46 (-0.33)
Stocks Mixed In Quiet Session; Pacira, Zoetis Ramp Higher
at Investor's Business Daily - Wed Feb 11, 12:26PM CST
Stocks were quietly mixed in early afternoon trading Wednesday as Greece started talks with eurozone finance ministers about a debt compromise. The Nasdaq picked up 0.2% while the S&P 500 and the Dow Jones industrial average lost 0.3% each. NYSE and...
ACHC: 63.20 (-0.45), ZTS: 45.46 (-0.33), TSLA: 203.77 (+0.89), FSLR: 48.84 (-0.58), AAPL: 127.08 (+0.62), PCRX: 113.94 (-0.91)
Don't Discount Bill Ackman
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 11:13AM CST
Originally Published on January 28, 2015 Bill Ackman wears an almost punchably smug expression. He looks as if he thinks that he is the smartest guy in any room. All the more grating is the fact that, in most rooms, he is right. He has reasons to...
ZTS: 45.46 (-0.33), AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), HHC: 144.41 (+6.41), TPRE: 13.91 (+0.03), PAH: 22.68 (+0.14), CP: 186.30 (-0.54), APD: 152.81 (+0.59), GLRE: 31.99 (+0.01)
Zoetis (ZTS) Stock Gains Today Following Earnings Beat
at The Street - Wed Feb 11, 10:07AM CST
Zoetis (ZTS) shares are rising after the company beat analysts' fourth quarter earnings and revenue expectations.
ZTS: 45.46 (-0.33)
Zoetis Beats on Q4 Earnings, Provides In-Line 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:56AM CST
Zoetis' fourth-quarter 2014 adjusted earnings of 40 cents per share were ahead of the Zacks Consensus Estimate.
ZTS: 45.46 (-0.33), ABT: 46.09 (+0.87), ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20)
Peak Pharmaceuticals Brings CBD-based Therapies to Pets
ACCESSWIRE - Wed Feb 11, 8:41AM CST
WHITEFISH, MT / ACCESSWIRE / February 11, 2015 / The medical marijuana industry has grown at a 16.2% CAGR between 2009 and 2014 to reach $2 billion in revenue, according to IBISWorld, driven by widespread legalization and promising new data from clinical trials. Some of the non-psychoactive cannabinoids found within the drug - including cannabidiol("CBD"
- could prove useful in treating conditions ranging from neurological diseases like Alzheimer's disease to metabolic diseases like diabetes or obesity.
ZTS: 45.46 (-0.33), GWPH: 78.09 (+1.70), PETM: 82.70 (+0.03)
Zoetis (ZTS) Beats on Q4 Earnings, Updates 2015 View - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:20AM CST
Zoetis (ZTS) Beats on Q4 Earnings, Updates 2015 View
ZTS: 45.46 (-0.33)
Zoetis Q4 net income up 20%
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:02AM CST
ZTS: 45.46 (-0.33)
Zoetis beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 6:02AM CST
ZTS: 45.46 (-0.33)
Zoetis Reports Fourth Quarter and Full Year 2014 Results
Business Wire - Wed Feb 11, 6:01AM CST
--Fourth Quarter 2014 Reported Net Income of $126 Million, or $0.25 per Diluted Share, Increased 20% and 19%, respectively
ZTS: 45.46 (-0.33)
Zoetis acquires animal health assets from Abbott for USD255m
M2 - Wed Feb 11, 4:32AM CST
Animal health company Zoetis (NYSE:ZTS) disclosed on Tuesday that it has completed the acquisition of the animal health assets of Abbott for a purchase price of USD255m upon fulfilling all closing requirements.
ZTS: 45.46 (-0.33)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Your Weekly Review: Growth Stocks Show Signs Of Life
at Investor's Business Daily - Thu Feb 12, 5:12PM CST
The good news for growth investors is that the market is back in a confirmed uptrend. Even better news is that this week's Your Weekly Review screen shows plenty of compelling candidates. Despite nagging distribution days in the S&P 500 and Nasdaq,...
CBPO: 69.12 (+0.42), ZTS: 45.46 (-0.33), SSNC: 63.38 (+1.40), AAP: 150.16 (-1.26), ORLY: 205.55 (-1.02), MIDD: 105.62 (+1.51), SPR: 49.35 (+0.47), MPWR: 50.32 (+0.16), DATA: 99.90 (+1.40)
Must-See Charts: 5 Big Stocks With Breakout Potential
at The Street - Thu Feb 12, 10:14AM CST
Here's a technical look at how to trade some of the biggest stocks on Wall Street.
ZTS: 45.46 (-0.33), BF.A: 90.65 (-0.43), IBM: 160.40 (+1.88), ABX: 12.14 (+0.01), IP: 57.31 (+0.12)
Company News for February 12, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 9:10AM CST
Companies in the News are: MOS,ZTS,TWX,VOYA
ZTS: 45.46 (-0.33), VOYA: 43.19 (+0.14), MOS: 52.33 (+0.29), TWX: 83.87 (+0.56)
Zoetis achieves higher Q4 2014 net income of USD126m
M2 - Thu Feb 12, 7:13AM CST
Animal medicine company Zoetis (NYSE:ZTS) stated on Wednesday that it recorded net income of USD126m, or USD0.25 per diluted share, for the fourth quarter 2014.
ZTS: 45.46 (-0.33)
Greece Issue Is Blown Out Of Proportion - Cramer's Mad Money (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 6:44AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, February 11. It is the overseas issue again. Cramer thinks the critics have come back to cause investor fear on the Germany-Greece showdown. Cramer called it...
PBR.A: 7.13 (+0.48), SDRL: 12.32 (-0.70), GOOG: 549.01 (+6.08), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), ZTS: 45.46 (-0.33), JNJ: 99.62 (+1.18), CMG: 674.89 (+4.60), DNB: 133.27 (+0.46), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), DOW: 49.44 (+0.29), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Zoetis
at Investor's Business Daily - Wed Feb 11, 6:01PM CST
Zoetis (ZTS) EPS rose 11.1% to 40 cents, topping by 4 cents. Revenue increased 3.8% to $1.3 bil, above views for $1.27 bil. The animal health company sees full-year EPS of $1.61-$1.68 on revenue of $4.8 bil-$4.9 bil. Shares rose 4.2% to 45.77.
ZTS: 45.46 (-0.33)
Zoetis (ZTS) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Wed Feb 11, 12:42PM CST
The following Zoetis (ZTS) conference call took place on February 11, 2015, 08:30 AM ET. This is a transcript of that earnings call:
ZTS: 45.46 (-0.33)
Stocks Mixed In Quiet Session; Pacira, Zoetis Ramp Higher
at Investor's Business Daily - Wed Feb 11, 12:26PM CST
Stocks were quietly mixed in early afternoon trading Wednesday as Greece started talks with eurozone finance ministers about a debt compromise. The Nasdaq picked up 0.2% while the S&P 500 and the Dow Jones industrial average lost 0.3% each. NYSE and...
ACHC: 63.20 (-0.45), ZTS: 45.46 (-0.33), TSLA: 203.77 (+0.89), FSLR: 48.84 (-0.58), AAPL: 127.08 (+0.62), PCRX: 113.94 (-0.91)
Don't Discount Bill Ackman
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 11:13AM CST
Originally Published on January 28, 2015 Bill Ackman wears an almost punchably smug expression. He looks as if he thinks that he is the smartest guy in any room. All the more grating is the fact that, in most rooms, he is right. He has reasons to...
ZTS: 45.46 (-0.33), AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), HHC: 144.41 (+6.41), TPRE: 13.91 (+0.03), PAH: 22.68 (+0.14), CP: 186.30 (-0.54), APD: 152.81 (+0.59), GLRE: 31.99 (+0.01)
Zoetis (ZTS) Stock Gains Today Following Earnings Beat
at The Street - Wed Feb 11, 10:07AM CST
Zoetis (ZTS) shares are rising after the company beat analysts' fourth quarter earnings and revenue expectations.
ZTS: 45.46 (-0.33)
Zoetis Beats on Q4 Earnings, Provides In-Line 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:56AM CST
Zoetis' fourth-quarter 2014 adjusted earnings of 40 cents per share were ahead of the Zacks Consensus Estimate.
ZTS: 45.46 (-0.33), ABT: 46.09 (+0.87), ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20)
Peak Pharmaceuticals Brings CBD-based Therapies to Pets
ACCESSWIRE - Wed Feb 11, 8:41AM CST
WHITEFISH, MT / ACCESSWIRE / February 11, 2015 / The medical marijuana industry has grown at a 16.2% CAGR between 2009 and 2014 to reach $2 billion in revenue, according to IBISWorld, driven by widespread legalization and promising new data from clinical trials. Some of the non-psychoactive cannabinoids found within the drug - including cannabidiol("CBD"
- could prove useful in treating conditions ranging from neurological diseases like Alzheimer's disease to metabolic diseases like diabetes or obesity. ZTS: 45.46 (-0.33), GWPH: 78.09 (+1.70), PETM: 82.70 (+0.03)
Zoetis (ZTS) Beats on Q4 Earnings, Updates 2015 View - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:20AM CST
Zoetis (ZTS) Beats on Q4 Earnings, Updates 2015 View
ZTS: 45.46 (-0.33)
Zoetis Q4 net income up 20%
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:02AM CST
ZTS: 45.46 (-0.33)
Zoetis beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 6:02AM CST
ZTS: 45.46 (-0.33)
Zoetis Reports Fourth Quarter and Full Year 2014 Results
Business Wire - Wed Feb 11, 6:01AM CST
--Fourth Quarter 2014 Reported Net Income of $126 Million, or $0.25 per Diluted Share, Increased 20% and 19%, respectively
ZTS: 45.46 (-0.33)
Zoetis acquires animal health assets from Abbott for USD255m
M2 - Wed Feb 11, 4:32AM CST
Animal health company Zoetis (NYSE:ZTS) disclosed on Tuesday that it has completed the acquisition of the animal health assets of Abbott for a purchase price of USD255m upon fulfilling all closing requirements.
ZTS: 45.46 (-0.33)
